Neuroendocrine Tumors Clinical Trials in Lexington, Kentucky

3 studies are recruiting for neuroendocrine tumors in Lexington, Kentucky right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

    The primary objectives are to determine the recommended Phase 2 dose (RP2D) and optimal treatment regimen, characterize safety and tolerability, and evaluate preliminary efficacy of RYZ401 in subjects with NETs and other selected solid tumors expressing SSTRs.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Research Facility, Lexington, Kentucky
    Locations
    14 in total
    Run by
    RayzeBio, Inc.

    See if you can join NCT07165132 on ClinicalTrials.gov

  2. A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

    This Phase 1/2, multicenter, open-label, FIH study aims to evaluate the safety, tolerability, PK, and preliminary antitumor activity of CRN09682 in participants with SST2-expressing NENs and other solid tumors. The study includes a Dose Escalation Phase to determine the MTD and DLTs. Following MTD …

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Crinetics Study Site, Lexington, Kentucky
    Locations
    27 in total
    Run by
    Crinetics Pharmaceuticals Inc.

    See if you can join NCT07129252 on ClinicalTrials.gov

  3. Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

    This study aims to determine the safety, pharmacokinetics (PK) and recommended Phase 3 dose (RP3D) of RYZ101 in Part 1, and the safety, efficacy, and PK of RYZ101 compared with investigator-selected standard of care (SoC) therapy in Part 2 in subjects with inoperable, advanced, well-differentiated,…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Research Facility, Lexington, Kentucky
    Locations
    54 in total
    Run by
    RayzeBio, Inc.

    See if you can join NCT05477576 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.